Alla Gabriella Wernicke
Research Subjects
Alla Gabriella Wernicke has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Bhupesh Parashar
25 shared publicationsDattatreyudu Nori
Stich Radiation Oncology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York
14 shared publicationsTheodore H. Schwartz
Department of Neurosurgery, Weill Medical College of Cornell University, New York, NY, United States
13 shared publicationsMenachem Z. Yondorf
9 shared publicationsPaul J. Christos
Division of Biostatistics and Epidemiology Department of Public Health Weill Cornell Medical College New York NY USA
9 shared publicationsAlbert Sabbas
8 shared publications
Latest Publications
- Open Access
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 12  (4) , 311-316
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
Purpose To compare treatment plans and evaluate dosimetric characteristics of permanent cesium-131 ( 131 Cs) vs. iodine-125 ( 125 I) implants used in brain brachytherapy. Material and methods Twenty-four patients with 131 Cs implants from a prospective phase I/II trial were re-planned with...
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 12  (4) , 311-316
Open AccessDosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
Purpose To compare treatment plans and evaluate dosimetric characteristics of permanent cesium-131 ( 131 Cs) vs. iodine-125 ( 125 I) implants used in brain brachytherapy. Material and methods Twenty-four patients with 131 Cs implants from a prospective phase I/II trial were re-planned with...
- Open Access
- 25 September 2019
- Published by Springer Nature in Cureus
- Vol. 11  (9) , e5762
The Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review
After maximally safe neurosurgical resection of brain metastases, stereotactic radiosurgery (SRS) is now recommended as an alternative to whole-brain radiation therapy (WBRT), which has been associated with cognitive decline. One complicating factor associated with SRS is that postoperative cavity dynamics can change dramatically, creating significant variability in the recommended timing of SRS. While SRS has been shown to improve local control (LC) in smaller tumor cavities, achieving excellent LC rates still remains a challenge in larger ones. Furthermore, factors predicting the optimal timing of SRS in relation to the cavity size need to be defined and implemented. Variables such as the delay between postoperative MRI and treatment are critical but poorly understood. One potential treatment option that may improve outcomes is brachytherapy, but the widespread implementation of this technique has been slow. This critical review analyzes the relationship between preoperative tumor volume, resection cavity size, and timing of SRS and explores how these variables must be understood in order to achieve the highest LC possible.
- 25 September 2019
- Published by Springer Nature in Cureus
- Vol. 11  (9) , e5762
Open AccessThe Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review
After maximally safe neurosurgical resection of brain metastases, stereotactic radiosurgery (SRS) is now recommended as an alternative to whole-brain radiation therapy (WBRT), which has been associated with cognitive decline. One complicating factor associated with SRS is that postoperative cavity dynamics can change dramatically, creating significant variability in the recommended timing of SRS. While SRS has been shown to improve local control (LC) in smaller tumor cavities, achieving excellent LC rates still remains a challenge in larger ones. Furthermore, factors predicting the optimal timing of SRS in relation to the cavity size need to be defined and implemented. Variables such as the delay between postoperative MRI and treatment are critical but poorly understood. One potential treatment option that may improve outcomes is brachytherapy, but the widespread implementation of this technique has been slow. This critical review analyzes the relationship between preoperative tumor volume, resection cavity size, and timing of SRS and explores how these variables must be understood in order to achieve the highest LC possible.
- 1 August 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 70, 30-37
An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy
- 1 August 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 70, 30-37
An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, 397-404
Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, 397-404
Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases
- Open Access
- 9 May 2019
- Published by Springer Nature in Cureus
- Vol. 11  (5) , e4629
Evidence for the Role of Mindfulness in Cancer: Benefits and Techniques
Mindfulness is being used increasingly in various aspects of cancer management. Benefits of mindfulness practices are being observed to manage the adverse effects of treatment, symptoms from cancer progression, and the cost-effectiveness compared to conventional contemporary management strategies. In this review article, we present clinical trial data showing the benefits of mindfulness in various aspects of cancer management as well as techniques that have been commonly used in this practice.
- 9 May 2019
- Published by Springer Nature in Cureus
- Vol. 11  (5) , e4629
Open AccessEvidence for the Role of Mindfulness in Cancer: Benefits and Techniques
Mindfulness is being used increasingly in various aspects of cancer management. Benefits of mindfulness practices are being observed to manage the adverse effects of treatment, symptoms from cancer progression, and the cost-effectiveness compared to conventional contemporary management strategies. In this review article, we present clinical trial data showing the benefits of mindfulness in various aspects of cancer management as well as techniques that have been commonly used in this practice.
- 1 May 2019
- Published by Elsevier in Brachytherapy
- Vol. 18  (3) , 258-270
Intraoperative brachytherapy for resected brain metastases
- 1 May 2019
- Published by Elsevier in Brachytherapy
- Vol. 18  (3) , 258-270
Intraoperative brachytherapy for resected brain metastases
- 1 May 2019
- Published by Elsevier in World Neurosurgery
- Vol. 125, 156-163
Reirradiation of Recurrent Brain Metastases: Where Do We Stand?
- 1 May 2019
- Published by Elsevier in World Neurosurgery
- Vol. 125, 156-163
Reirradiation of Recurrent Brain Metastases: Where Do We Stand?
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 11  (4) , 356-360
Placement of 131 Cs permanent brachytherapy seeds in a large combined cavity of two resected brain metastases in one setting: case report and technical note
Large brain metastases are presently treated with surgical resection and adjuvant radiotherapy. However, local control (LC) for large tumors decreases from over 90% to as low as 40% as the tumor/cavity increases. Intraoperative brachytherapy is one of the focal radiotherapy techniques, which...
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 11  (4) , 356-360
Open AccessPlacement of 131 Cs permanent brachytherapy seeds in a large combined cavity of two resected brain metastases in one setting: case report and technical note
Large brain metastases are presently treated with surgical resection and adjuvant radiotherapy. However, local control (LC) for large tumors decreases from over 90% to as low as 40% as the tumor/cavity increases. Intraoperative brachytherapy is one of the focal radiotherapy techniques, which...
- Open Access
- 15 November 2018
- Published by Springer Nature in Cureus
- Vol. 10  (11) , e3596
Temporal Changes in Esophageal Cancer Mortality by Geographic Region: A Population-based Analysis
To analyze differences in esophageal cancer survival by geographic region of the U.S. from the 1970s to the 2000s, and attribute the causes of these discrepancies. Raw data were obtained from the Surveillance Epidemiology and End Results (SEER) program of the National Cancer Institute. Patients were stratified by decade of diagnosis and by geographic region (East, Hawaii/Alaska, Midwest, Southwest, and West), containing SEER registries. The Kaplan-Meier method with the log-rank test was used to compare the overall survival (OS) among these geographic groups. A multivariate Cox Proportional Hazard analysis was conducted to evaluate the impact of the following factors on differences in survival: patient age, gender, race, tumor stage, site, histology, treatment method, and metropolitan size. A total of 87,834 patients were identified. OS has increased significantly since 1973, with five-year OS improving from 4.9% (the 1970s) to 15.3% (2000s) (PP<0.001). The multivariate analysis revealed increased age, African American race, distant disease, non-distal tumor location, squamous cell histology, and no radiation therapy were associated with worse OS. The West and East had the highest amount of cancer centers (12 and seven, respectively). And the East had the highest number of cancer centers per person (5.7E-07) while the South had the lowest (1.6E-07). There are disparities in esophageal cancer survival and quality of care through different geographic regions of the U.S., which may be attributed to a combination of the unbalanced distribution of medical resources, the regional differences in cancer biology, and other lifestyle and socioeconomic factors. More research should be conducted to further characterize regional differences and guide the implementation of improvements in survival.
- 15 November 2018
- Published by Springer Nature in Cureus
- Vol. 10  (11) , e3596
Open AccessTemporal Changes in Esophageal Cancer Mortality by Geographic Region: A Population-based Analysis
To analyze differences in esophageal cancer survival by geographic region of the U.S. from the 1970s to the 2000s, and attribute the causes of these discrepancies. Raw data were obtained from the Surveillance Epidemiology and End Results (SEER) program of the National Cancer Institute. Patients were stratified by decade of diagnosis and by geographic region (East, Hawaii/Alaska, Midwest, Southwest, and West), containing SEER registries. The Kaplan-Meier method with the log-rank test was used to compare the overall survival (OS) among these geographic groups. A multivariate Cox Proportional Hazard analysis was conducted to evaluate the impact of the following factors on differences in survival: patient age, gender, race, tumor stage, site, histology, treatment method, and metropolitan size. A total of 87,834 patients were identified. OS has increased significantly since 1973, with five-year OS improving from 4.9% (the 1970s) to 15.3% (2000s) (PP<0.001). The multivariate analysis revealed increased age, African American race, distant disease, non-distal tumor location, squamous cell histology, and no radiation therapy were associated with worse OS. The West and East had the highest amount of cancer centers (12 and seven, respectively). And the East had the highest number of cancer centers per person (5.7E-07) while the South had the lowest (1.6E-07). There are disparities in esophageal cancer survival and quality of care through different geographic regions of the U.S., which may be attributed to a combination of the unbalanced distribution of medical resources, the regional differences in cancer biology, and other lifestyle and socioeconomic factors. More research should be conducted to further characterize regional differences and guide the implementation of improvements in survival.
- Open Access
- 12 November 2018
- Published by Springer Nature in Cureus
- Vol. 10  (11) , e3575
Survival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level
This study evaluates regional poverty level-dependent differences in lung cancer (LC) survival, focusing on patients receiving radiation therapy (RT). The Surveillance, Epidemiology, and End Results (SEER) database was used to retrospectively identify patients diagnosed with LC between 2000 and 2009. Patients were divided into socioeconomic status (SES) quintiles, with quintiles 1 and 5 representing the highest and lowest SES cohorts, respectively. The Kaplan-Meier method with the log-rank test was used to compare overall survival (OS) from diagnosis between demographic and clinical factor levels. Multivariate (MVA) Cox proportional hazards regression was used to examine the association of quintile and mortality, adjusting for demographic and clinical factors. Compared to those not receiving RT, the univariate (UVA) results showed a higher mortality associated with receiving RT (HR:1.091; CI:1.081-1.102) while the MVA demonstrated a protective effect (HR:0.882; CI:0.873-0.891). The MVA revealed that men had higher mortality rates than women (HR:1.192; CI:1.180-1.203). Caucasians had a lower mortality rate as compared to African Americans (adjusted HR:0.932; CI:0.918-0.947) while Asians, Pacific Islanders, and Native Americans had the highest overall survival rates (adjusted HR:0.752, CI:0.734-0.771). Among the entire study population, quintile 2 (HR:1.059, CI:1.043-1.076), quintile 3 (HR:1.091, CI:1.075-1.108), quintile 4 (HR:1.094, CI:1079-1.110), and quintile 5 (HR:1.201, CI:1.181-1.221) reported increased mortality rates compared with quintile 1. This trend was also observed among those undergoing RT, with quintile 2 (HR:1.034, CI:1.010-1.059), quintile 3 (HR:1.045; CI:1.021-1.069), quintile 4 (HR:1.056; CI:1.033-1.080), and quintile 5 (HR:1.153; CI:1.124-1.183) demonstrating incrementally worse OS. Upon accounting for age, gender, race, SES, and tumor stage, RT may provide a positive survival benefit among those who received treatment. Minimal differences existed among SES quintiles regarding diagnoses made by tumor stage or patients receiving RT. An incrementally worse OS rate was associated with increasing regional poverty level. This trend persevered among those receiving RT.
- 12 November 2018
- Published by Springer Nature in Cureus
- Vol. 10  (11) , e3575
Open AccessSurvival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level
This study evaluates regional poverty level-dependent differences in lung cancer (LC) survival, focusing on patients receiving radiation therapy (RT). The Surveillance, Epidemiology, and End Results (SEER) database was used to retrospectively identify patients diagnosed with LC between 2000 and 2009. Patients were divided into socioeconomic status (SES) quintiles, with quintiles 1 and 5 representing the highest and lowest SES cohorts, respectively. The Kaplan-Meier method with the log-rank test was used to compare overall survival (OS) from diagnosis between demographic and clinical factor levels. Multivariate (MVA) Cox proportional hazards regression was used to examine the association of quintile and mortality, adjusting for demographic and clinical factors. Compared to those not receiving RT, the univariate (UVA) results showed a higher mortality associated with receiving RT (HR:1.091; CI:1.081-1.102) while the MVA demonstrated a protective effect (HR:0.882; CI:0.873-0.891). The MVA revealed that men had higher mortality rates than women (HR:1.192; CI:1.180-1.203). Caucasians had a lower mortality rate as compared to African Americans (adjusted HR:0.932; CI:0.918-0.947) while Asians, Pacific Islanders, and Native Americans had the highest overall survival rates (adjusted HR:0.752, CI:0.734-0.771). Among the entire study population, quintile 2 (HR:1.059, CI:1.043-1.076), quintile 3 (HR:1.091, CI:1.075-1.108), quintile 4 (HR:1.094, CI:1079-1.110), and quintile 5 (HR:1.201, CI:1.181-1.221) reported increased mortality rates compared with quintile 1. This trend was also observed among those undergoing RT, with quintile 2 (HR:1.034, CI:1.010-1.059), quintile 3 (HR:1.045; CI:1.021-1.069), quintile 4 (HR:1.056; CI:1.033-1.080), and quintile 5 (HR:1.153; CI:1.124-1.183) demonstrating incrementally worse OS. Upon accounting for age, gender, race, SES, and tumor stage, RT may provide a positive survival benefit among those who received treatment. Minimal differences existed among SES quintiles regarding diagnoses made by tumor stage or patients receiving RT. An incrementally worse OS rate was associated with increasing regional poverty level. This trend persevered among those receiving RT.